Olympus Launches ENDO-AID, an AI-Powered Platform for Its Endoscopy System
- 2020年10月09日 18:00:00
- テクノロジー
- JCN Newswire
As a global leader in designing and delivering innovative solutions for medical and surgical procedures, Olympus aims to improve the health and quality of life of patients by providing advanced medical technologies. Its latest endoscopy system, EVIS X1, was developed to set new standards for image detection, characterization, staging, and treatment. With the newly introduced endoscopy CAD (computer-aided detection/diagnosis) platform ENDO-AID, Olympus is now enhancing the capabilities of EVIS X1 through AI technology, aiming to elevate the standard of endoscopy around the world - whether for applications to disorders of the esophagus, stomach, colon or other gastrointestinal organs.
ENDO-AID CADe: real-time computer-aided detection for endoscopy
ENDO-AID CADe is an application for computer-aided detection powered by AI which runs on ENDO-AID. It uses a complex algorithm via a neural network developed and trained by Olympus. With this new application, the system's sophisticated machine learning can alert the endoscopist in real time when a suspected colonic lesion (such as a polyp, malignant neoplasm or adenoma) appears on the screen.
ENDO-AID CADe was developed toward the following improvements:
- Improved observational performance in adenoma detection: By providing visual support, ENDO-AID CADe aims to improve the observational performance of the endoscopist's adenoma detection.
- Support of the colonoscopy screening process: The system provides visual support during screening, allowing the endoscopist to focus on any abnormalities indicated by the software regardless of the experience level of the endoscopist.
- Efficient endoscopy operation: Due to the simple and intuitive display of lesions, ENDO-AID CADe has the potential to make endoscopy easier and more efficient for the endoscopist by reducing the need for excessive eye movements.
A first step towards the future of endoscopic diagnosis and therapy
With ENDO-AID, the latest feature of the EVIS X1 endoscopy system, Olympus has created the basis and infrastructure for the installation of future applications supported by AI. "At Olympus we are committed to innovation and driving our research and development with passion,"says Frank Drewalowski, Head of Endoscopic Solutions Division, Olympus Corporation. "Especially in AI, we recognize the power of elevating endoscopic imaging to uncharted levels. Considering ENDO-AID as a first step, we are planning additional AI-powered applications for image detection and characterization - not only for colonoscopy."
Prevention of colorectal cancer remains our focus
There is a positive impact of an increase in adenoma detection rate (ADR) on the prevention of colorectal cancer (CRC)(2). Supporting the identification of lesions, ENDO-AID CADe is designed to increase ADR(3). We are aiming to increase the quality of CRC screening and its preventive efficacy against CRC. The prevention of CRC is a core element of Olympus'endeavors in medical endoscopy and beyond.
"With the launch of ENDO-AID, we are not only providing endoscopists across the world with an additional innovative tool,"says Takaharu Yamada, Vice President, GI Endoscopy Business Leader, Endoscopic Solutions Division. "We are also preparing for the future and following our vision of putting CRC in the history books."
Official launch at United European Gastroenterology Week (UEGW)
During the virtual UEGW from October 11 to 13, ENDO-AID will be presented to the public for the first time. ENDO-AID is initially and commercially being launched in Europe beginning in November, followed shortly afterwards by some Middle Eastern, African and Asian-Pacific countries. Japan, the Americas and China markets will follow at a later time after complying with laws and regulations in each region. EVIS X1 and ENDO-AID are manufactured by Olympus Medical Systems Corporation. The company and product names specified in this release are the trademarks or registered trademarks of Olympus.
(1) Product Name: Endoscopy CAD system
(2) Corley, D.A.;Jensen, C.D.;Marks, A.R.;et al. Adenoma Detection Rate and Risk of Colorectal Cancer and Death. N Engl J Med. 2014;370: 1298-1306. Available at:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036494/. Accessed in October 2020
(3) Compared to WLI (white light imaging) without CADe
About Olympus
Olympus is passionate about the solutions it creates for the medical, life sciences, and industrial equipment industries, as well as cameras and audio products. For more than 100 years, Olympus has focused on making people's lives healthier, safer, and more fulfilling by helping detect, prevent, and treat disease, furthering scientific research, ensuring public safety, and capturing images of the world.
Olympus Endoscopic Solutions uses innovative capabilities in medical technology, therapeutic intervention, and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic, and minimally invasive procedures to improve clinical outcomes, reduce overall costs, and enhance the quality of life for patients. Starting with the world's first gastrocamera in 1950, Olympus'endoscopic portfolio has grown to include endoscopes, laparoscopes, and video imaging systems, as well as systems integration solutions and medical services.
For questions or additional information, please contact:
Europe, Middle East and Africa
Matthias Gengenbach
+49 15142369420
matthias.gengenbach@olympus-europa.com
Japan
Yuka Horimoto
+81 90 2490 1071
yuka_horimoto@ot.olympus.co.jp
Asia Pacific
Oliver Clarke
+61 3 9271 5508
oliver.clarke@olympus.com.au
Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com
及川奈央が興奮「学生時代から大好きだった」推しバンドのライブで「涙が止まらず」
犯罪心理学者が指摘する水原一平被告の「最大の謎」「おっかなくなる人がほとんどだが」
【オリックス】育成出身佐藤一磨プロ初登板初先発で5回無失点の好投 勝利投手の権利持って降板
【日本ハム】加藤貴之7回87球無失点で降板 投直が左肩付近に直撃するアクシデントの影響か
河合優実「恥ずかしくてプロフィルから消したもん」こっそり楽しむ趣味明かし照れ笑い
36歳辻希美、夫杉浦太陽との「離婚危機」衝撃告白 藤本美貴驚き「ええ?」
前澤友作氏、宮城県で行われたレースで接触事故に見舞われ救急搬送、命に別条なし
【阪神】才木浩人ノーノーならず 8回1死から山野辺翔に三塁打許す、甲子園はため息と声援
ケネディ氏を阻む米大統領選討論会の参加基準の壁 クリアなるか
今いくよさん、坂田利夫さんとの“恋バナ”の真相 くるよさんとの絆 「さんまのまんま」再放送
何があった!?「エアコン」が想定外の壊れ具合!投稿者に話を聞いた
深田えいみ、ビキニ姿で「じゃーん!Jカップ」報告に「成長中」「まジェーっすか」「重そう」
玉置浩二の妻、青田典子(53)の現在がとんでもない事になっていると話題に
歌手の門倉有希さん 乳がんのため死去、50歳「6月6日に永眠」所属事務所が発表
柏原崇(45)現在を調べてみた結果、相変わらずかっこよすぎた!
三上悠亜、整形したことを事後報告でネット騒然「素っぴんが美しすぎる」「大半を既にいじっておいて今更」
ユーチューバーもこう氏、元彼女・成海瑠奈について赤裸々告白
橋本環奈すぎと話題呼んだアイドル中川心、動画披露し「無加工でこれはやっぱり本物」と反響の声
元「うたのお兄さん」横山だいすけ「NHK出入り禁止になる」 濱家の直球質問にオロオロ
眞鍋かをりさん、ワイドナショーでド正論を言っただけでマスコミにまで炎上させられる異常事態
何があった!?「エアコン」が想定外の壊れ具合!投稿者に話を聞いた
柏原崇(45)現在を調べてみた結果、相変わらずかっこよすぎた!
玉置浩二の妻、青田典子(53)の現在がとんでもない事になっていると話題に
ユーチューバーもこう氏、元彼女・成海瑠奈について赤裸々告白
元めちゃイケメンバーの三中元克(32)現在は何をしているのか調べてみた!
ガーシーが綾野剛のLINE公開でネット騒然「ショック」「すごいエンタメ」
小倉優子、不自然な“二重ライン”にネット騒然「やっぱり整形?」
TikTokを賑わす「フエラムネごめんなサイダー味」がセブンイレブンで再販!じゅるるマスカットも買うなら今!
岡本夏生(56)、1600日ぶりにブログを更新した現在が衝撃
浜崎あゆみ、子供の写真公開に疑いの声止まず「よそのお宅の子供?」
及川奈央が興奮「学生時代から大好きだった」推しバンドのライブで「涙が止まらず」
犯罪心理学者が指摘する水原一平被告の「最大の謎」「おっかなくなる人がほとんどだが」
【オリックス】育成出身佐藤一磨プロ初登板初先発で5回無失点の好投 勝利投手の権利持って降板
【日本ハム】加藤貴之7回87球無失点で降板 投直が左肩付近に直撃するアクシデントの影響か
河合優実「恥ずかしくてプロフィルから消したもん」こっそり楽しむ趣味明かし照れ笑い
前澤友作氏、宮城県で行われたレースで接触事故に見舞われ救急搬送、命に別条なし
36歳辻希美、夫杉浦太陽との「離婚危機」衝撃告白 藤本美貴驚き「ええ?」
【阪神】才木浩人ノーノーならず 8回1死から山野辺翔に三塁打許す、甲子園はため息と声援
ケネディ氏を阻む米大統領選討論会の参加基準の壁 クリアなるか
今いくよさん、坂田利夫さんとの“恋バナ”の真相 くるよさんとの絆 「さんまのまんま」再放送